{"id":1419,"date":"2025-12-22T01:07:09","date_gmt":"2025-12-22T00:07:09","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/event\/high-endothelial-venules-hevs-specialized-blood-vessels-for-lymphocyte-entry-in-tumors-during-cancer-immunotherapy-tijc-11\/"},"modified":"2025-12-26T01:55:36","modified_gmt":"2025-12-26T00:55:36","slug":"high-endothelial-venules-hevs-specialized-blood-vessels-for-lymphocyte-entry-in-tumors-during-cancer-immunotherapy-tijc-11","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/high-endothelial-venules-hevs-specialized-blood-vessels-for-lymphocyte-entry-in-tumors-during-cancer-immunotherapy-tijc-11\/","title":{"rendered":"High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy #TIJC 11"},"content":{"rendered":"

WEBINAR Transdisciplinary Immunology Journal Club #TIJC10<\/strong><\/span><\/span>
<\/strong><\/span>With Lucas Blanchard
<\/strong><\/span>High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy
<\/strong><\/span>Thursday, November 20, 2025 – From 4:00 PM to 5:00 PM<\/span><\/span><\/h4>\n

\"TIJC11.jpeg\"<\/a><\/h4>\n

 <\/p>\n

Revoir en Replay TIJC#10
NK cells regulate CD8+ T cells via PD-1\/PD-L1 & Immunotherapy-Induced Colitis par David ZEMMOUR, MD, PhD \u2013 University of Chicago<\/p>\n<\/p>\n

Revoir en Replay TIJC#7
Anti-PD-1 amplifies co-stimulation in melanoma-infiltrating Th1-like Foxp3+ Regulatory T cells to alleviate local immunosuppression<\/strong> par Dr Mikha\u00ebl ATTIAS<\/p>\n

 <\/p>\n

Revoir en Replay TIJC#6bis
HLA class I peptide polymorphisms contribute to class II DQ\u03b20603:DQ\u03b10103 antibody specificity<\/strong> par le Dr C\u00e9dric Usureau<\/p>\n

Revoir en Replay TIJC#6
Evolution of myeloid-mediated immunotherapy resistance in prostate cancer : Lyu A & al. Nature.2025 <\/strong> par le Dr Simon COIBA, disponible ICI<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#5
Neoantigen vaccines: a new era of precision medicine in oncology<\/strong> par le Dr Adrien MOUREN, disponible ICI<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#4
Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division (Nat Immunol.)<\/strong> par le Dr Matthieu Roulleau Dugage, disponible ICI
<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#3
Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed. 
<\/strong>With Dr Marie ROBERT. REPLAY HERE ! <\/a><\/strong><\/p>\n<\/p>\n

Revoir en Replay TIJC#2
The type 2 cytokine Fc\u2013IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024. <\/strong>Par le Dr Fran\u00e7ois-Xavier Danlos, disponible ICI<\/a><\/p>\n<\/p>\n

Revoir en Replay TIJC#1
JAK Inhibitors and Cancer: Friend or Foe? <\/strong>Par le Dr Samuel Bitoun, disponible ICI<\/a><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"

WEBINAR Transdisciplinary Immunology Journal Club #TIJC10With Lucas BlanchardHigh endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapyThursday, November 20, 2025 – From 4:00 PM to 5:00 PM   Revoir en Replay TIJC#10NK cells regulate CD8+ T cells via PD-1\/PD-L1 & Immunotherapy-Induced Colitis par David ZEMMOUR, MD, PhD \u2013 University of Chicago Revoir […]<\/p>\n","protected":false},"author":1,"featured_media":1420,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"event_date":"Thursday, November 20, 2025 ","event_location":"online webinar","event_time":"From 4:00 PM to 5:00 PM","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=1419"}],"version-history":[{"count":3,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1419\/revisions"}],"predecessor-version":[{"id":2496,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1419\/revisions\/2496"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/1420"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=1419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=1419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=1419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}